ELEV

Elevation Oncology (ELEV)

Elevation Oncology Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ELEV

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/18	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/05/10	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ELEV	Elevation Oncology Inc
2024/05/10	05:39	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ELEV	Elevation Oncology Inc
2024/05/07	20:30	PR Newswire (US)	Elevation Oncology to Present at the Citizens JMP Life Sciences Conference	NASDAQ:ELEV	Elevation Oncology Inc
2024/05/02	20:30	PR Newswire (US)	Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements	NASDAQ:ELEV	Elevation Oncology Inc
2024/04/09	05:30	PR Newswire (US)	Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	22:14	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	21:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	21:30	PR Newswire (US)	Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	21:00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/06	06:50	PR Newswire (US)	Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/05	06:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/05	06:21	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/03/04	21:30	PR Newswire (US)	Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/28	21:30	PR Newswire (US)	Elevation Oncology to Participate in Upcoming Investor Conferences	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/22	21:30	PR Newswire (US)	Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/21	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/21	06:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/21	06:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/02/15	06:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/24	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/23	06:57	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/23	06:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/23	06:24	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/22	21:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/22	21:30	PR Newswire (US)	Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/10	06:24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/05	21:40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELEV	Elevation Oncology Inc
2024/01/05	21:30	PR Newswire (US)	Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones	NASDAQ:ELEV	Elevation Oncology Inc
2023/11/22	21:30	PR Newswire (US)	Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:ELEV	Elevation Oncology Inc